Literature DB >> 11154621

Drug Points: pancreatitis associated with hydroxyurea in combination with didanosine.

H J Longhurst1, A J Pinching.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11154621      PMCID: PMC26596          DOI: 10.1136/bmj.322.7278.81

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance.

Authors:  F Lori; A G Malykh; A Foli; R Maserati; A De Antoni; L Minoli; D Padrini; A Degli Antoni; E Barchi; H Jessen; M A Wainberg; R C Gallo; J Lisziewicz
Journal:  AIDS Res Hum Retroviruses       Date:  1997-11-01       Impact factor: 2.205

2.  The Alpha trial: European/Australian randomized double-blind trial of two doses of didanosine in zidovudine-intolerant patients with symptomatic HIV disease. Alpha International Coordinating Committee.

Authors: 
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

  2 in total
  4 in total

Review 1.  Pancreatogenic Diabetes: Triggering Effects of Alcohol and HIV.

Authors:  Moses New-Aaron; Murali Ganesan; Raghubendra Singh Dagur; Kusum K Kharbanda; Larisa Y Poluektova; Natalia A Osna
Journal:  Biology (Basel)       Date:  2021-02-03

Review 2.  A cure for AIDS: a matter of timing?

Authors:  Iart Luca Shytaj; Andrea Savarino
Journal:  Retrovirology       Date:  2013-11-22       Impact factor: 4.602

Review 3.  Antiretroviral drugs and acute pancreatitis in HIV/AIDS patients: is there any association? A literature review.

Authors:  Natalia Mejias Oliveira; Felipe Augusto Yamauti Ferreira; Raquel Yumi Yonamine; Ethel Zimberg Chehter
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar

4.  The Risk of Chronic Pancreatitis in Patients with Psoriasis: A Population-Based Cohort Study.

Authors:  Hsien-Yi Chiu; Chi-Feng Hsieh; Yi-Ting Chiang; Weng-Foung Huang; Tsen-Fang Tsai
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.